KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Total Liabilities (2016 - 2026)

Neogenomics filings provide 17 years of Total Liabilities readings, the most recent being $517.8 million for Q1 2026.

  • On a quarterly basis, Total Liabilities fell 27.4% to $517.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $517.8 million, a 27.4% decrease, with the full-year FY2025 number at $523.3 million, down 28.87% from a year prior.
  • Total Liabilities hit $517.8 million in Q1 2026 for Neogenomics, down from $523.3 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $754.5 million in Q1 2022 to a low of $517.8 million in Q1 2026.
  • Median Total Liabilities over the past 5 years was $732.9 million (2024), compared with a mean of $686.8 million.
  • Biggest five-year swings in Total Liabilities: grew 15.96% in 2022 and later fell 28.87% in 2025.
  • Neogenomics' Total Liabilities stood at $742.0 million in 2022, then decreased by 0.31% to $739.7 million in 2023, then dropped by 0.54% to $735.7 million in 2024, then fell by 28.87% to $523.3 million in 2025, then dropped by 1.05% to $517.8 million in 2026.
  • The last three reported values for Total Liabilities were $517.8 million (Q1 2026), $523.3 million (Q4 2025), and $536.5 million (Q3 2025) per Business Quant data.